Wright J A, Smith H S, Watt F M, Hancock M C, Hudson D L, Stark G R
Imperial Cancer Research Fund Laboratories, London, United Kingdom.
Proc Natl Acad Sci U S A. 1990 Mar;87(5):1791-5. doi: 10.1073/pnas.87.5.1791.
Three types of normal human cells were selected in tissue culture with three drugs without observing a single amplification event from a total of 5 x 10(8) cells. No drug-resistant colonies were observed when normal foreskin keratinocytes were selected with N-(phosphonacetyl)-L-aspartate or with hydroxyurea or when normal mammary epithelial cells were selected with methotrexate. Some slightly resistant colonies with limited potential for growth were obtained when normal diploid fibroblast cells derived from fetal lung were selected with methotrexate or hydroxyurea but careful copy-number analysis of the dihydrofolate reductase and ribonucleotide reductase genes revealed no evidence of amplification. The rarity of DNA amplification in normal human cells contrasts strongly with the situation in tumors and in established cell lines, where amplification of oncogenes and of genes mediating drug resistance is frequent. The results suggest that tumors and cell lines have acquired the abnormal ability to amplify DNA with high frequency.
在组织培养中选用了三种正常人类细胞,并使用三种药物进行处理,对总共5×10⁸个细胞进行观察,未发现单一的扩增事件。当用N-(膦酰乙酰基)-L-天冬氨酸或羟基脲筛选正常包皮角质形成细胞时,以及当用甲氨蝶呤筛选正常乳腺上皮细胞时,均未观察到耐药菌落。当用甲氨蝶呤或羟基脲筛选源自胎儿肺的正常二倍体成纤维细胞时,获得了一些生长潜力有限的轻度耐药菌落,但对二氢叶酸还原酶和核糖核苷酸还原酶基因进行仔细的拷贝数分析后,未发现扩增的证据。正常人类细胞中DNA扩增的罕见情况与肿瘤和已建立的细胞系中的情况形成强烈对比,在肿瘤和细胞系中,癌基因和介导耐药性的基因频繁扩增。结果表明,肿瘤和细胞系已经获得了高频扩增DNA的异常能力。